Does BRIGATINIB Cause Performance status decreased? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Performance status decreased have been filed in association with BRIGATINIB (Alunbrig). This represents 0.2% of all adverse event reports for BRIGATINIB.
8
Reports of Performance status decreased with BRIGATINIB
0.2%
of all BRIGATINIB reports
3
Deaths
3
Hospitalizations
How Dangerous Is Performance status decreased From BRIGATINIB?
Of the 8 reports, 3 (37.5%) resulted in death, 3 (37.5%) required hospitalization.
Is Performance status decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BRIGATINIB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does BRIGATINIB Cause?
Death (405)
Non-small cell lung cancer (370)
Off label use (256)
Diarrhoea (239)
Metastases to central nervous system (219)
Nausea (218)
Lung neoplasm malignant (216)
Fatigue (201)
Blood creatine phosphokinase increased (198)
Product dose omission issue (193)
What Other Drugs Cause Performance status decreased?
BACLOFEN (156)
LENALIDOMIDE (118)
PACLITAXEL (112)
BEVACIZUMAB (103)
SODIUM OXYBATE (103)
CARBOPLATIN (100)
DEXAMETHASONE (80)
CAPECITABINE (75)
NIRAPARIB (75)
LUMATEPERONE (68)
Which BRIGATINIB Alternatives Have Lower Performance status decreased Risk?
BRIGATINIB vs BRILINTA
BRIGATINIB vs BRILIQUE
BRIGATINIB vs BRIMONIDINE
BRIGATINIB vs BRIMONIDINE\BRINZOLAMIDE
BRIGATINIB vs BRIMONIDINE\TIMOLOL